Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 37Neoplasms 2Neoplasm Metastasis 2Venous Thromboembolism 1Recurrent Squamous Cell Lung Carcinoma 1Hormone Receptor Positive Advanced Breast Cancer 1HER2-positive Metastatic Breast Cancer 1DILI 1Cardiovascular Diseases 1Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1Breast Neoplasms, Male 1Breast Diseases 1

Interventions

palbociclib 1Fulvestrant 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × HER2-positive Metastatic Breast Cancer × palbociclib × Clear all
NCT04778982 2023-07-17

Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Terminated
4 enrolled
Breast

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡